{
  "node_id": "ich-s9-nonclinical-anticancer-pharmaceutical-2010",
  "title": "ICH S9 - Nonclinical Evaluation for Anticancer Pharmaceuticals: Timing of Studies, General Toxicology, Genotoxicity and Reproductive Toxicology",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.0",
  "last_updated": "2026-04-20",
  "bluf": "This regulation requires that nonclinical studies for anticancer pharmaceuticals be conducted in accordance with ICH S9, specifically…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "industry_mapping"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "ich-gcp-e6-r3-2023"
  ],
  "primary_citations_count": 5,
  "workflow_steps_count": 10,
  "schema_fields_count": 10,
  "citation_preview": [
    "ICH S9, Section 3 - Timing of Nonclinical Studies",
    "ICH S9, Section 4 - General Toxicology"
  ]
}